Calls
21
#18
Alpha Score 98.3
TheLAPurchaser
L/S Equity trader
Win Rate
75.0%
return
+17.4%
Loading charts...
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
May 07
$27.74
-5.4%
Buy WRBY for direct exposure to the AI wearables theme, with a near-term catalyst from Google I/O next week and a clear product roadmap in 2H, supported by mass-market retail partnership.
Buy WRBY for direct exposure to the AI wearables theme, with a near-term catalyst from Google I/O next week and a clear product roadmap in 2H, supported by mass-market retail partnership.
Retail & Mobility
Long
Mar 16
$441.00
+91.2%
The author expresses strong optimism for the semiconductor supply chain and related stocks following Nvidia's capacity expansion comments.
The author expresses strong optimism for the semiconductor supply chain and related stocks following Nvidia's capacity expansion comments.
AI Memory
Long
Mar 11
$651.99
+106.3%
The user anticipates significant growth in SanDisk's run rate earnings per share.
AI Memory
Long
Apr 21
$194.90
-
Long DIM.FP due to strong order growth in bioprocessing equipment (>30% in Q1), indicating a sustained recovery and acceleration in the bioprocessing thematic.
Long DIM.FP due to strong order growth in bioprocessing equipment (>30% in Q1), indicating a sustained recovery and acceleration in the bioprocessing thematic.
Diagnostics
Long
Mar 16
$182.98
+10.6%
The author expresses strong optimism for the semiconductor supply chain and related stocks following Nvidia's capacity expansion comments.
The author expresses strong optimism for the semiconductor supply chain and related stocks following Nvidia's capacity expansion comments.
AI Compute
Long
Mar 14
$191.39
+5.2%
The tweet implies positive growth prospects for the bioprocessing sector.
Diagnostics
Long
Mar 14
$115.11
+27.9%
The tweet implies positive growth prospects for the bioprocessing sector.
Diagnostics
Long
Mar 14
$470.00
+13.4%
The tweet implies positive growth prospects for the bioprocessing sector.
Diagnostics
Long
May 12
$518.36
+0.4%
Buy SOXX as the pain trade (short squeeze / positioning) drives semis higher near-term.
Thematic ETFs
Long
Apr 30
$901.21
+30.6%
Buy LLY on strong earnings beat and EPS raise, with ex-US blowouts supporting the upside despite structural concerns.
Buy LLY on strong earnings beat and EPS raise, with ex-US blowouts supporting the upside despite structural concerns.
GLP-1 / Obesity
Long
Apr 28
$1038.99
+20.1%
Buy FICO on oversold conditions with management signaling stock too cheap sub-$1200 and an annualized buyback rate of 10% of shares outstanding as a catalyst.
Buy FICO on oversold conditions with management signaling stock too cheap sub-$1200 and an annualized buyback rate of 10% of shares outstanding as a catalyst.
Capital Markets
Short
Apr 27
$220.60
+9.8%
Short RMD due to GLP-1-driven CPAP attrition, slowing growth into FY27, and no multi-product floor for a single-product medtech.
Short RMD due to GLP-1-driven CPAP attrition, slowing growth into FY27, and no multi-product floor for a single-product medtech.
MedTech
Long
Apr 23
$116.30
+15.3%
Long SOXL or semiconductor supply chain names after Jensen Huang’s statement that NVDA needs much more capacity, signaling broad demand tailwinds.
Long SOXL or semiconductor supply chain names after Jensen Huang’s statement that NVDA needs much more capacity, signaling broad demand tailwinds.
Thematic ETFs
Long
Apr 22
$252.49
-2.3%
Buy AMZN because its pharmacy expansion leverages existing same-day delivery logistics and One Medical's digital script capabilities to capture consumer healthcare spend and data, starting with GLP-1 medications.
Buy AMZN because its pharmacy expansion leverages existing same-day delivery logistics and One Medical's digital script capabilities to capture consumer healthcare spend and data, starting with GLP-1 medications.
Hyperscalers
Long
Apr 22
$451.93
-23.4%
Buy ISRG as Q1 results show strong margin expansion and record buybacks, while the stock trades at a historically low forward P/E with an AI-enabled product catalyst on the horizon.
Buy ISRG as Q1 results show strong margin expansion and record buybacks, while the stock trades at a historically low forward P/E with an AI-enabled product catalyst on the horizon.
MedTech
Showing 15 of 21 calls · sorted by mentions
Choose a mentions count to open ticker posts.
TheLAPurchaser has 21 trade ideas tracked on Buzzberg across 21 tickers since March 2026. Win rate 75% across 20 evaluated calls, average return +17.4%. Ranked #18 on the Buzzberg Alpha leaderboard. Most covered: WRBY, SNDK, MU.
